ILANA MULLER: Open Payments
NPI 1306512066 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,894 in 81 payments from 15 companies in 2025. Trend: 2023 $945 · 2024 $1,608 · 2025 $1,894
Food & beverage: $1,894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $608 |
| QOL Medical, LLC | 11 | $306 |
| GENZYME CORPORATION | 10 | $266 |
| Phathom Pharmaceuticals, Inc. | 3 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| Janssen Biotech, Inc. | 6 | $130 |
| PFIZER INC. | 3 | $60 |
| Madrigal Pharmaceuticals | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Celltrion USA Inc. | 1 | $33 |
Products named: Sucraid, DUPIXENT, RINVOQ, VOQUEZNA, SKYRIZI, ENTYVIO, TREMFYA, CREON.
Industry payments across FL — which companies pay providers there.
